Revolution Medicines Inc.

NASDAQ: RVMD · Real-Time Price · USD
36.30
0.28 (0.78%)
At close: Aug 15, 2025, 3:59 PM
36.32
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT

Revolution Medicines Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 11.58M 35.38M 29.39M
Cost of Revenue
11.82M 9.31M 9.66M 7.33M
Gross Profit
-11.82M 11.58M 35.38M 29.39M
Operating Income
-689.52M -487.19M -258.28M -188.01M
Interest Income
86.88M 47.48M 9.15M 929K
Pretax Income
-600.85M -439.89M -249.13M -187.09M
Net Income
-600.09M -436.37M -248.71M -187.09M
Selling & General & Admin
97.3M 75.62M 40.59M 30.45M
Research & Development
592.23M 423.14M 253.07M 186.95M
Other Expenses
-11.82M -9.31M -9.66M -7.33M
Operating Expenses
677.7M 489.46M 284M 210.07M
Interest Expense
n/a n/a n/a 12K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
689.52M 498.76M 293.66M 217.4M
Income Tax Expense
753K -3.52M -420K n/a
Shares Outstanding (Basic)
167.74M 113.15M 80.63M 72.81M
Shares Outstanding (Diluted)
167.74M 113.15M 80.63M 72.81M
EPS (Basic)
-3.58 -3.86 -3.08 -2.47
EPS (Diluted)
-3.58 -3.86 -3.08 -2.47
EBITDA
-589.02M -477.88M -248.62M -179.75M
EBIT
-600.85M -487.19M -258.28M -187.08M
Depreciation & Amortization
11.82M 9.31M 9.66M 7.33M